Purple Biotech Ltd. (PPBT.TA)
ILA 6.9
(-4.17%)
ILA 6.9
(-4.17%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -19.92 Million | -16.73 Million | -15.07 Million | -12.09 Million | -5.58 Million | -8.48 Million |
| Net Income | -19.97 Million | -21.76 Million | -17.82 Million | -28.07 Million | -5.89 Million | -5.56 Million |
| Depreciation & Amortization | 197 Thousand | 201 Thousand | 231 Thousand | 235 Thousand | 179 Thousand | 7000.00 |
| Deferred income taxes | - | - | - | - | - | -894 Thousand |
| Stock-based compensation | 1.87 Million | 2.41 Million | 2.08 Million | 2.64 Million | 1.27 Million | 773 Thousand |
| Change in working capital | 274 Thousand | 3.25 Million | 550 Thousand | -2.36 Million | 340 Thousand | -540 Thousand |
| Other non-cash items | -2.29 Million | -843 Thousand | -108 Thousand | 15.46 Million | -1.47 Million | -2.25 Million |
| Investing Cash Flow | 13.88 Million | 19.91 Million | 13.4 Million | -49.59 Million | -449 Thousand | 2.04 Million |
| Investments in PPE | -3000.00 | -228 Thousand | -115 Thousand | -156 Thousand | -11 Thousand | -16 Thousand |
| Acquisitions | -3.54 Million | - | - | 69 Thousand | - | - |
| Investment purchases | - | - | - | -49.61 Million | -2.1 Million | - |
| Sales/Maturities of investments | 16.67 Million | 19.81 Million | 13.16 Million | 41 Thousand | 1.51 Million | - |
| Other Investing Activities | 755 Thousand | 324 Thousand | 359 Thousand | 69 Thousand | 151 Thousand | 2.06 Million |
| Financing Cash Flow | 5.44 Million | 1.11 Million | 1.51 Million | 68.48 Million | 5.23 Million | 7.78 Million |
| Debt repayment | -168 Thousand | -165 Thousand | -153 Thousand | -188 Thousand | -171 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.56 Million | 1.49 Million | 564 Thousand | 27.92 Million | 2.59 Million | 4.68 Million |
| Other Financing Activities | 4.05 Million | -219 Thousand | 1.1 Million | 40.75 Million | 2.81 Million | 3.1 Million |
| Accounts receivables | - | 313 Thousand | -316 Thousand | 501 Thousand | 1555.00 | -1.11 Million |
| Accounts payables | 1.33 Million | 799 Thousand | 266 Thousand | -2.33 Million | 503 Thousand | 393 Thousand |
| Inventory | - | 2.13 Million | 573 Thousand | -511 Thousand | -1555.00 | - |
| Other working capital | -1.06 Million | 11 Thousand | 27 Thousand | -20 Thousand | -163 Thousand | -933 Thousand |
| Cash at beginning of period | 15.03 Million | 10.89 Million | 11.24 Million | 4.38 Million | 5.16 Million | 3.94 Million |
| Cash at end of period | 14.48 Million | 15.03 Million | 10.89 Million | 11.24 Million | 4.38 Million | 5.16 Million |
| Capital Expenditure | -3000.00 | -228 Thousand | -115 Thousand | -156 Thousand | -11 Thousand | -16 Thousand |
| Effect of forex changes on cash | 54 Thousand | -153 Thousand | -24 Thousand | 61 Thousand | 19 Thousand | -136 Thousand |
| Net cash flow / Change in cash | -541 Thousand | 4.14 Million | -357 Thousand | 6.86 Million | -778 Thousand | 1.21 Million |
| Free Cash Flow | -19.92 Million | -16.96 Million | -15.18 Million | -12.24 Million | -5.59 Million | -8.49 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.41 Million | -3.78 Million | -19.97 Million | -4.85 Million | -5.05 Million | -5.16 Million |
| Depreciation & Amortization | 49 Thousand | 48 Thousand | 197 Thousand | 48 Thousand | 50 Thousand | 53 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 218 Thousand | 266 Thousand | 1.87 Million | 181 Thousand | 449 Thousand | 493 Thousand |
| Change in working capital | -1.05 Million | -930 Thousand | 274 Thousand | 1.05 Million | 1.59 Million | -634 Thousand |
| Other non-cash items | -975 Thousand | -685 Thousand | -2.29 Million | -1.4 Million | -692 Thousand | 25 Thousand |
| Investing Cash Flow | 87 Thousand | 312 Thousand | 13.88 Million | 74 Thousand | 1 Million | 198 Thousand |
| Investments in PPE | - | - | -3000.00 | - | 1000.00 | -1000.00 |
| Acquisitions | - | - | -3.54 Million | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 5000.00 | 187 Thousand | 16.67 Million | -6000.00 | 878 Thousand | 3000.00 |
| Other Investing Activities | 87.00 | 312.00 | 755 Thousand | 80 Thousand | 127 Thousand | 196 Thousand |
| Financing Cash Flow | 433 Thousand | 268 Thousand | 5.44 Million | 4.24 Million | 572 Thousand | 367 Thousand |
| Debt repayment | -46 Thousand | -45 Thousand | -168 Thousand | -42 Thousand | -42 Thousand | -42 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 564 Thousand | 374 Thousand | 1.56 Million | 4000.00 | 678 Thousand | 486 Thousand |
| Other Financing Activities | -75 Thousand | -50 Thousand | 4.05 Million | 4.28 Million | -64 Thousand | -77 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -444 Thousand | -46 Thousand | 1.33 Million | 919 Thousand | 1.04 Million | -878 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -409.00 | -884.00 | -1.06 Million | 137 Thousand | 549 Thousand | 244 Thousand |
| Cash at beginning of period | 9.98 Million | 14.48 Million | 15.03 Million | 15.1 Million | 17.2 Million | 21.88 Million |
| Cash at end of period | 6.52 Million | 9.98 Million | 14.48 Million | 14.48 Million | 15.1 Million | 17.2 Million |
| Capital Expenditure | - | - | -3000.00 | - | 1000.00 | -1000.00 |
| Effect of forex changes on cash | -5000.00 | -2000.00 | 54 Thousand | 47 Thousand | -20 Thousand | -23 Thousand |
| Net cash flow / Change in cash | -3.46 Million | -4.5 Million | -541 Thousand | -615 Thousand | -2.09 Million | -4.68 Million |
| Free Cash Flow | -3.97 Million | -5.08 Million | -19.92 Million | -4.98 Million | -3.65 Million | -5.22 Million |
1445
6265
THOXF
TALBROAUTO
AGTT
TEF